Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension

NCT04787445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2024-03-21

No results posted yet for this study

Summary

The purpose of this study is to characterize the clinical and hemodynamic response of Pulmonary Arterial Hypertension (PAH) therapy in patients with atypical PAH and risk factors for left heart disease.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Yogesh N Reddy, MBBS · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-11
Primary Completion
2023-11-21
Completion
2023-11-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04787445 on ClinicalTrials.gov